These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15139487)

  • 1. Nizatidine and cisapride increase salivary secretion in rats.
    Adachi K; Furuta K; Katsube T; Fujisawa T; Azumi T; Fujishiro H; Ishihara S; Amano Y; Kinoshita Y
    Dig Dis Sci; 2004 Mar; 49(3):399-403. PubMed ID: 15139487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nizatidine and cisapride enhance salivary secretion in humans.
    Adachi K; Ono M; Kawamura A; Yuki M; Fujishiro H; Kinoshita Y
    Aliment Pharmacol Ther; 2002 Feb; 16(2):297-301. PubMed ID: 11860413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroprokinetic activity of nizatidine during the digestive state in the dog and rat.
    Ueki S; Matsunaga Y; Yoneta T; Tamaki H; Itoh Z
    Arzneimittelforschung; 1999 Jul; 49(7):618-25. PubMed ID: 10442211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
    Ueki S; Seiki M; Yoneta T; Aita H; Chaki K; Hori Y; Morita H; Tagashira E; Itoh Z
    J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicarbonate stimulatory action of nizatidine, a histamine H(2)-receptor antagonist, in rat duodenums.
    Mimaki H; Kawauchi S; Kagawa S; Ueki S; Takeuchi K
    J Physiol Paris; 2001; 95(1-6):165-71. PubMed ID: 11595432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nizatidine enhances salivary secretion in patients with dry mouth.
    Nin T; Umemoto M; Negoro A; Miuchi S; Sakagami M
    Auris Nasus Larynx; 2008 Jun; 35(2):224-9. PubMed ID: 18082986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
    Lin TM; Evans DC; Warrick MW; Pioch RP
    J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nizatidine accelerates gastric emptying of a solid meal in rats.
    Kaneko H; Mitsuma T; Uchida K; Nagai H; Harada M; Kotera H
    Dig Dis Sci; 1995 Sep; 40(9):2043-51. PubMed ID: 7555463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid inhibitory characteristics of nizatidine in man: an overview.
    Parente F; Bianchi Porro G
    Scand J Gastroenterol Suppl; 1994; 206():3-7. PubMed ID: 7863250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of various histamine H2-receptor antagonists on gastrointestinal motility and gastric emptying].
    Ohira Y; Hanyu N; Aoki T; Hashimoto Y; Iikura M; Fukuda S
    J Smooth Muscle Res; 1993 Aug; 29(4):131-42. PubMed ID: 7907895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity.
    Caballería J; Baraona E; Deulofeu R; Hernández-Muñoz R; Rodés J; Lieber CS
    Dig Dis Sci; 1991 Dec; 36(12):1673-9. PubMed ID: 1684149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous nizatidine kinetics and acid suppression.
    Callaghan JT; Bergstrom RF; Obermeyer BD; King EP; Offen WW
    Clin Pharmacol Ther; 1985 Feb; 37(2):162-5. PubMed ID: 2857117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the H2-antagonists famotidine and nizatidine and the cytoprotectant misoprostol on human colonic and rat peritoneal mast cells.
    Shah PM; Boulos PB; Springall R; Vashisht R; Pearce FL
    Agents Actions; 1994 Jun; 41 Spec No():C51-2. PubMed ID: 7976805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of previous administration of nizatidine on the neuromuscular effects of vecuronium and the effect of nizatidine on gastric secretion.
    Wajima Z; Shitara T; Inoue T; Yoshikawa T; Ogawa R
    Anaesth Intensive Care; 2000 Feb; 28(1):46-8. PubMed ID: 10701036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an oral evening dose of nizatidine on nocturnal and peptone-stimulated gastric acid and gastrin secretion.
    Kovacs TO; Van Deventer GM; Maxwell V; Sytnik B; Walsh JH
    Scand J Gastroenterol Suppl; 1987; 136():41-6. PubMed ID: 2892254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of 24-hour acidity by nizatidine].
    Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
    Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine and nizatidine stimulate antral smooth muscle contractility via excitatory cholinergic mechanisms.
    Parkman HP; Pagano AP; Ryan JP
    Dig Dis Sci; 1998 Mar; 43(3):497-505. PubMed ID: 9539643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the new anti-ulcer drug nizatidine on prostaglandins in the rat gastric mucosa.
    Segawa Y; Takei M; Omata T; Tsuzuike N; Yamaji Y; Kurimoto T; Ozeki M; Tagashira E
    Arzneimittelforschung; 1991 Sep; 41(9):950-3. PubMed ID: 1796923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
    Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation by nizatidine, a histamine H(2)-receptor antagonist, of duodenal HCO(3)(-)secretion in rats:relation to anti-cholinesterase activity.
    Takeuchi K; Kawauchi S; Araki H; Ueki S; Furukawa O
    World J Gastroenterol; 2000 Oct; 6(5):651-658. PubMed ID: 11819669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.